Login to Your Account



Pharma: Other News To Note


Tuesday, November 13, 2012
• Watson Pharmaceuticals Inc., of Parsippany, N.J., said subsidiary Watson Laboratories Inc. received FDA approval on its abbreviated new drug application for sildenafil tablets, 20 mg, the generic equivalent to New York-based Pfizer Inc.'s Revatio, for the treatment of pulmonary arterial hypertension in adults to improve exercise ability and delay clinical worsening.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription